Healthcare -
Biotechnology - NASDAQ - US
$ 7.29
-14.1 %
$ 755 M
Market Cap
-1.38
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Intellia Therapeutics, Inc.
| Net Income | -519 M |
| Depreciation & Amortization | 10.3 M |
| Capital Expenditures | -5.78 M |
| Stock-Based Compensation | 154 M |
| Change in Working Capital | 0 |
| Others | -17.3 M |
| Free Cash Flow | -355 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (519.0) | (481.2) | (474.2) | (267.9) | (134.2) | (99.5) | (85.3) | (67.5) | (31.6) | (12.4) | (14.3) |
| Depreciation & Amortization | 10.3 | 9.0 | 7.6 | 6.9 | 6.3 | 5.6 | 4.5 | 3.0 | 1.1 | 0.3 | 4.5 K |
| Deferred Income Tax | 0 | 0 | 0 | 8.9 | 0 | 0 | 0 | 0 | (6.7) | (1.0) | 0 |
| Stock Based Compensation | 154.3 | 134.1 | 91.4 | 47.0 | 19.9 | 15.1 | 17.0 | 15.3 | 6.7 | 1.3 | 0.5 |
| Other Operating Activities | 5.6 | (3.5) | 95.8 | 2.9 | 0.6 | (3.7) | (0.6) | 0.2 | 6.7 | 9 K | 9.3 |
| Change in Working Capital | 0 | (52.5) | (53.9) | (22.9) | 57.5 | (20.7) | 3.2 | (16.2) | 59.9 | 10.0 | 1.0 |
| Cash From Operations | (348.9) | (394.1) | (333.3) | (225.0) | (49.9) | (103.2) | (61.3) | (65.3) | 36.1 | (1.8) | (3.5) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | (5.8) | (14.0) | (58.4) | (12.8) | (3.6) | (6.8) | (6.4) | (10.1) | (6.2) | (2.6) | (0.4) |
| Other Items | 131.3 | (17.4) | 218.7 | (538.0) | (210.9) | 32.0 | (254.4) | 0 | 0 | 0 | (0.5) |
| Cash From Investing Activities | 125.6 | (31.3) | 160.3 | (550.8) | (214.5) | 25.2 | (260.8) | (10.1) | (6.2) | (2.6) | (0.9) |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (2.7) | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 8.8 | 10.5 | 17.2 | 43.1 | 13.1 | 4.2 | 11.7 | 2.0 | (3.2) | 70.3 | 19.1 |
| Cash From Financing Activities | 185.7 | 130.3 | 583.0 | 736.7 | 371.8 | 76.4 | 40.2 | 143.0 | 167.3 | 70.3 | 19.1 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | (37.6) | (295.1) | 410.0 | (39.1) | 107.4 | (1.6) | (281.8) | 67.6 | 197.2 | 66.0 | 14.8 |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | (354.7) | (408.1) | (391.7) | (237.8) | (53.5) | (110.0) | (67.6) | (75.4) | 29.9 | (4.3) | (3.9) |